DIAMEDICA THERAPEUTICS INC (DMAC) Stock Balance Sheet
NASDAQ:DMAC - Nasdaq - CA25253X2077 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 4.13M | 4.54M | 4.73M | 4.71M | 7.41M | |||
| Marketable Securities | 46.06M | 48.35M | 28.77M | 40.41M | 20.10M | |||
| Receivables | 290.00K | 369.00K | 80.00K | 130.00K | 340.00K | |||
| Other Current Assets | 280.00K | 411.00K | 250.00K | 190.00K | 70.00K | |||
| Total Current Assets | 50.77M | 53.67M | 33.84M | 45.44M | 27.92M | |||
| Non-Current Assets | ||||||||
| PPE Net | 449.00K | 485.00K | 560.00K | 110.00K | 170.00K | |||
| Other Non-Current Assets | 1.31M | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.76M | 485.00K | 560.00K | 110.00K | 180.00K | |||
| TOTAL ASSETS | 52.52M | 54.16M | 34.40M | 45.55M | 28.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 14.00K | 3.00K | 10.00K | 0.00 | 10.00K | |||
| Accrued Expenses | 3.11M | 1.86M | 1.43M | 1.01M | 920.00K | |||
| Accounts Payable | 1.17M | 926.00K | 730.00K | 510.00K | 1.10M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.30M | 2.79M | 2.17M | 1.52M | 2.03M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 249.00K | 1.00K | 0.00 | 0.00 | 10.00K | |||
| Other Non-Current Liabilities | 14.00K | 316.00K | 400.00K | 0.00 | 50.00K | |||
| Total Non-Current Liabilities | 263.00K | 317.00K | 400.00K | 10.00K | 50.00K | |||
| TOTAL LIABILITIES | 4.56M | 3.10M | 2.57M | 1.53M | 2.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -132.10M | -115.56M | -96.18M | -82.50M | -68.91M | |||
| Additional Paid In Capital | 179.99M | 166.61M | 128.08M | 126.58M | 94.93M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 81.00K | 6.00K | -70.00K | -50.00K | 0.00 | |||
| Shares Outstanding | 42.77M | 37.96M | 26.44M | 26.44M | 18.75M | |||
| Tangible Book Value per Share | 1.12 | 1.35 | 1.20 | 1.66 | 1.39 | |||
| Total Shareholders' Equity | 47.96M | 51.06M | 31.83M | 44.02M | 26.01M | |||
| TOTAL LIABILITIES AND EQUITY | 52.52M | 54.16M | 34.40M | 45.55M | 28.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.00 | N/A | N/A | 0.00 | |||
| Current Ratio | 11.81 | 19.27 | 15.59 | 29.89 | 13.75 | |||
| Return On Assets (ROA) | -41.32% | -35.78% | -39.77% | -29.84% | -43.74% | |||
| Return On Equity (ROE) | -45.25% | -37.96% | -42.98% | -30.87% | -47.25% | |||
All data in USD , ROIC based on taxRate of 0.21